High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study

M. Terwijn; W.L.J. van Putten; A. Kelder; V.H.J. Velden van der; R.A. Brooimans; T. Pabst; J. Maertens; N. Boeckx; G.E. de Greef; P.J.M. Valk; F.W.M.B. Preijers; P.C. Huijgens; A.M. Drager; U. Schanz; M. Jongen-Lavrencic; B.J. Biemond; J. Passweg; M. van Gelder; P.W. Wijermans; C. Graux; M. Bargetzi; M-C. Legdeur; J.H.E. Kuball; O. de Weerdt; [No Value] et al; G.J. Schuurhuis

High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study

M. Terwijn, W.L.J. van Putten, A. Kelder, V.H.J. Velden van der, R.A. Brooimans, T. Pabst, J. Maertens, N. Boeckx, G.E. de Greef, P.J.M. Valk, F.W.M.B. Preijers, P.C. Huijgens, A.M. Drager, U. Schanz, M. Jongen-Lavrencic, B.J. Biemond, J. Passweg, M. van Gelder, P.W. Wijermans, C. GrauxM. Bargetzi, M-C. Legdeur, J.H.E. Kuball, O. de Weerdt, [No Value] et al, G.J. Schuurhuis

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	3889-3897
Number of pages	9
Journal	Journal of Clinical Oncology
Volume	31
Issue number	31
Publication status	Published - 2013

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/24062400

Cite this

Terwijn, M., van Putten, W. L. J., Kelder, A., Velden van der, V. H. J., Brooimans, R. A., Pabst, T., Maertens, J., Boeckx, N., de Greef, G. E., Valk, P. J. M., Preijers, F. W. M. B., Huijgens, P. C., Drager, A. M., Schanz, U., Jongen-Lavrencic, M., Biemond, B. J., Passweg, J., van Gelder, M., Wijermans, P. W., ... Schuurhuis, G. J. (2013). High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study. Journal of Clinical Oncology, 31(31), 3889-3897. http://www.ncbi.nlm.nih.gov/pubmed/24062400

@article{32b7135cfb0f44879134c3928efa4a98,

title = "High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study",

author = "M. Terwijn and {van Putten}, W.L.J. and A. Kelder and {Velden van der}, V.H.J. and R.A. Brooimans and T. Pabst and J. Maertens and N. Boeckx and {de Greef}, G.E. and P.J.M. Valk and F.W.M.B. Preijers and P.C. Huijgens and A.M. Drager and U. Schanz and M. Jongen-Lavrencic and B.J. Biemond and J. Passweg and {van Gelder}, M. and P.W. Wijermans and C. Graux and M. Bargetzi and M-C. Legdeur and J.H.E. Kuball and {de Weerdt}, O. and {et al}, {[No Value]} and G.J. Schuurhuis",

year = "2013",

language = "English",

volume = "31",

pages = "3889--3897",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "31",

}

Terwijn, M, van Putten, WLJ, Kelder, A, Velden van der, VHJ, Brooimans, RA, Pabst, T, Maertens, J, Boeckx, N, de Greef, GE, Valk, PJM, Preijers, FWMB, Huijgens, PC, Drager, AM, Schanz, U, Jongen-Lavrencic, M, Biemond, BJ, Passweg, J, van Gelder, M, Wijermans, PW, Graux, C, Bargetzi, M, Legdeur, M-C, Kuball, JHE, de Weerdt, O, et al, NV & Schuurhuis, GJ 2013, 'High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study', Journal of Clinical Oncology, vol. 31, no. 31, pp. 3889-3897. <http://www.ncbi.nlm.nih.gov/pubmed/24062400>

TY - JOUR

T1 - High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study

AU - Terwijn, M.

AU - van Putten, W.L.J.

AU - Kelder, A.

AU - Velden van der, V.H.J.

AU - Brooimans, R.A.

AU - Pabst, T.

AU - Maertens, J.

AU - Boeckx, N.

AU - de Greef, G.E.

AU - Valk, P.J.M.

AU - Preijers, F.W.M.B.

AU - Huijgens, P.C.

AU - Drager, A.M.

AU - Schanz, U.

AU - Jongen-Lavrencic, M.

AU - Biemond, B.J.

AU - Passweg, J.

AU - van Gelder, M.

AU - Wijermans, P.W.

AU - Graux, C.

AU - Bargetzi, M.

AU - Legdeur, M-C.

AU - Kuball, J.H.E.

AU - de Weerdt, O.

AU - et al, [No Value]

AU - Schuurhuis, G.J.

PY - 2013

Y1 - 2013

M3 - Article

SN - 0732-183X

VL - 31

SP - 3889

EP - 3897

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 31

ER -